P53 Codon 72 (Arg72Pro) Polymorphism and Prostate Cancer Risk: Association between Disease Onset and Proline Genotype

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pathobiology (Basel)

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000326767PMID 21778786
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis

  2011cited by this paper
• Differential levels of transcription of p53‐regulated genes by the arginine/proline polymorphism: p53 with arginine at codon 72 favors apoptosis

  2010cited by this paper
• p53-family proteins and their regulators: hubs and spokes in tumor suppression

  2010cited by this paper
• Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.

  2010cited by this paper
• p53 Pro72Arg polymorphism and prostate cancer in men of African descent

  2010cited by this paper
• Estimates of cancer incidence and mortality in Europe in 2008.

  2010cited by this paper
• Genetic polymorphisms and early-onset prostate cancer: a real potential to personalize prostate cancer screening?

  2009cited by this paper
• The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models

  2009cited by this paper
• TNM Classification of Malignant Tumours, 7th Edition

  2009cited by this paper
• Tumour suppression by p53: a role for the DNA damage response?

  2009cited by this paper
• p53 polymorphisms: cancer implications

  2009cited by this paper
• Analysis of TP53 codon 72 polymorphism in HPV-positive and HPV-negative penile carcinoma.

  2008cited by this paper
• KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations

  2008cited by this paper
• [HPV in non-gynecological tumors].

  2008cited by this paper
• HPV bei nichtgynäkologischen Tumoren

  2008cited by this paper
• CXCL12 G801A Polymorphism Is a Risk Factor for Sporadic Prostate Cancer Susceptibility

  2007cited by this paper
• Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer

  2007cited by this paper
• p53 ubiquitination: Mdm2 and beyond.

  2006cited by this paper
• p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer

  2006cited by this paper
• Polymorphic variants in the p53 pathway

  2006cited by this paper
• Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina

  2005cited by this paper
• Molecular pathology of prostate cancer

  2005cited by this paper
• Regulation of Apoptosis in Prostate Cancer

  2004cited by this paper
• World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs

  2004cited by this paper
• p53 Moves to Mitochondria: A Turn on the Path to Apoptosis

  2004cited by this paper
• p53 Gene Codon 72 Polymorphism but Not Tumor Necrosis Factor-α Gene Is Associated with Prostate Cancer

  2004cited by this paper
• p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.

  2004cited by this paper
• P53 gene Codon 72 Polymorphism But Not Tumor Necrosis Factor-a Gene Is Associated with Prostate Cancer.

  2004cited by this paper
• Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

  2003cited by this paper
• Tumours of the prostate.

  2001cited by this paper
• Association of codon 72 polymorphism of p53 with lower prostate cancer risk

  2001cited by this paper
• Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically

  1999cited by this paper
• Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer

  1998cited by this paper
• TNM Classification of Malignant Tumors

  1998cited by this paper
• p53, the Cellular Gatekeeper Review for Growth and Division

  1997cited by this paper
• An uncertain role for p53 gene alterations in human prostate cancers.

  1996cited by this paper
• Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males

  1996cited by this paper
• P53 mutations and loss of heterozygosity on chromosomes 8p, 16q, 17p, and 18q are confined to advanced prostate cancer.

  1994cited by this paper
• Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer.

  1994cited by this paper
• Codon 72 polymorphism of the TP53 gene.

  1990cited by this paper

• Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis

  2025cites this paper
• Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer

  2025cites this paper
• TP53 Codon 72 Polymorphism Impacts Macrophage Activation through Reactive Oxygen Species-Dependent Cell Signaling Alterations.

  2024cites this paper
• Molecular detection of a polymorphism in the p53 codon 72 gene and its association with prostate cancer

  2022cites this paper
• Homologous recombination repair gene mutations in Malaysian prostate cancer patients.

  2022cites this paper
• Ethnicity-stratified analysis of the association between P53 rs1042522 polymorphism and women HPV infection: A meta-analysis.

  2021cites this paper
• The Relationship of Gliomas with Tp53 Rs1042522 C > G And Gliomas in Duhok

  2020cites this paper
• Linkage disequilibrium and haplotypes of five TP53 polymorphisms in oesophageal cancer patients

  2020cites this paper
• Association between TP53 gene codon72 polymorphism and prostate cancer risk

  2019cites this paper
• A systematic review and meta-analysis

  2019cites this paper
• Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model

  2019cites this paper
• P53 Codon 72 Polymorphism and Risk for Squamous Cell Carcinoma of the Penis: A Caucasian Case-Control Study

  2018cites this paper
• TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status

  2018cites this paper
• Genetic alterations in benign prostatic hyperplasia patients

  2017cites this paper
• Association between the rs1042522 polymorphism in TP53 and prostate cancer risk: An updated meta-analysis

  2017cites this paper
• Worldwide Prevalence of Human Papillomavirus and Relative Risk of Prostate Cancer: A Meta-analysis

  2015cites this paper
• MDM2 and P53 polymorphisms contribute together to the risk and survival of prostate cancer

  2015cites this paper
• Analysis of TP 53 Polymorphisms in North Indian Sporadic Esophageal Cancer Patients

  2014cites this paper
• Current clinical application and future prospects

  2014cites this paper
• Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients.

  2014cites this paper
• Prostate specific antigen. Current clinical application and future prospects.

  2014cites this paper
• Association of p53 codon 72 polymorphism with prostate cancer: an update meta-analysis

  2014cites this paper
• Association of the rs1042522 polymorphism with increased risk of prostate adenocarcinoma in the Pakistani population and its HuGE review.

  2014cites this paper
• Alterations in TP53 gene – Implications in Tumorigenesis Process and Prognosis in Central Nervous System Cancer

  2014cites this paper
• Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.

  2014cites this paper
• Molecular Pathways in Prostate Cancer

  2013cites this paper
• Is Human Papillomavirus Associated with Prostate Cancer Survival?

  2013cites this paper
• Association of p53 codon 72 genotypes and clinical outcome in human papillomavirus-infected lung cancer patients.

  2013cites this paper
• Infections and inflammation in prostate cancer.

  2013cites this paper
• Meta‐analysis of the association between P53 codon 72 polymorphisms and gastric cancer

  2013cites this paper
• Polymorphisms in TP53 (rs1042522), p16 (rs11515 and rs3088440) and NQO1 (rs1800566) genes in Thai cervical cancer patients with HPV 16 infection.

  2013cites this paper
• The Pro/Pro genotype at TP53 codon 72 polymorphism is associated with early onset glioblastoma.

  2012cites this paper
• Multigene panels in prostate cancer risk assessment.

  2012cites this paper
• Structure and Dynamics of the p53 Transactivation Domain Binding to MDM2 and RPA70

  2012influential citation
• Biomarkers in Prostate Cancer Epidemiology

  2011cites this paper
• Association of p53 codon 72 polymorphism with prostate cancer: a meta-analysis

  2011cites this paper